89bio, Inc. - COM (ETNB)

Historical Portfolio Holders from Q4 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
104M
Holdings value Q3 2024
$773M
Value change Q3 2024
+$3.44M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
142
Number of buys Q3 2024
79
Number of sells Q3 2024
-53
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 104M $773M +$3.44M $7.40 143
2024 Q2 103M $822M +$24.3M $8.01 142
2024 Q1 97.7M $1.14B +$49.2M $11.64 149
2023 Q4 93.6M $1.05B +$191M $11.17 151
2023 Q3 71.9M $1.11B -$105M $15.44 165
2023 Q2 77.2M $1.46B +$132M $18.95 157
2023 Q1 71M $1.08B +$393M $15.23 149
2022 Q4 46.3M $589M +$135M $12.73 106
2022 Q3 39.2M $227M +$45.5M $5.79 85
2022 Q2 32.5M $105M +$48M $3.22 67
2022 Q1 17.1M $64.3M -$14.9M $3.77 65
2021 Q4 17.3M $226M -$710K $13.07 49
2021 Q3 17.3M $339M +$9.16M $19.59 48
2021 Q2 16.9M $315M -$5.58M $18.70 50
2021 Q1 16.9M $401M +$4.52M $23.68 67
2020 Q4 16.7M $407M +$14.9M $24.37 69
2020 Q3 16M $411M +$130M $25.66 68
2020 Q2 10.4M $207M -$1.58M $19.93 36
2020 Q1 10.7M $270M +$7.52M $25.25 30
2019 Q4 10.4M $275M +$272M $26.29 34